Foundation for innovation
in Cardiometabolism and Nutrition

Evaluation of PXL065 – deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1)

Journal of Hepatology

Evaluation of PXL065 – deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1)

Posted on 

ISO 9001 Certified

OUr Institutionnal Supporters

Our network